Form CORRESP - Correspondence:
SEC Accession No. 0001193125-19-165029
Filing Date
2019-06-04
Accepted
2019-06-04 16:01:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 6068
  Complete submission text file 0001193125-19-165029.txt   6980
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

EIN.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2835 In Vitro & In Vivo Diagnostic Substances